Investigation of the Anti-Methicillin-Resistant <i>Staphylococcus aureus</i> Activity of (+)-Tanikolide- and (+)-Malyngolide-Based Analogues Prepared by Asymmetric Synthesis

Herein, we report antibacterial and antifungal evaluation of a series of previously prepared (+)-tanikolide analogues. One analogue, (4<i>S</i>,6<i>S</i>)-4-methyltanikolide, displayed promising anti-methicillin-resistant <i>Staphylococcus aureus</i> activity with...

Full description

Bibliographic Details
Main Authors: Joseph Breheny, Cian Kingston, Robert Doran, Joao Anes, Marta Martins, Séamus Fanning, Patrick J. Guiry
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/12/6400
Description
Summary:Herein, we report antibacterial and antifungal evaluation of a series of previously prepared (+)-tanikolide analogues. One analogue, (4<i>S</i>,6<i>S</i>)-4-methyltanikolide, displayed promising anti-methicillin-resistant <i>Staphylococcus aureus</i> activity with a MIC of 12.5 µg/mL. Based on the antimicrobial properties of the structurally related (−)-malyngolide, two further analogues (4<i>S</i>,6<i>S</i>)-4-methylmalyngolide and (4<i>R</i>,6<i>S</i>)-4-methylmalyngolide bearing a shortened <i>n</i>-nonyl alkyl side chain were prepared in the present study using a ZrCl<sub>4</sub>-catalysed deprotection/cyclisation as the key step in their asymmetric synthesis. When these were tested for activity against anti-methicillin-resistant <i>Staphylococcus aureus</i>, the MIC increased to 50 µg/mL.
ISSN:1661-6596
1422-0067